Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) — Corporate Action | 23 September 2026

23 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Acquisition of Wellness Portfolio from Group Pharmaceuticals

🔄 What Changed

Initial consideration of ₹23.7 crores with up to ₹46.7 crores total consideration; completion deadline of 01 November, 2026

🔮 What's Next

Completion by 01 November, 2026, subject to conditions

💡 Investor Takeaway

This acquisition expands Jagsonpal's women's health portfolio and market reach through a strategic purchase.

Jagsonpal Pharmaceuticals announced on September 23, 2026, its agreement to acquire the Wellness Portfolio of Group Pharmaceuticals for an initial consideration of ₹23.7 crores, with up to ₹46.7 crores total consideration tied to FY 2027-28 sales performance, targeting completion by November 1, 2026, to expand its women's health presence.

📄 View Original Announcement (PDF)

📊 Stock Analysis — JAGSNPHARM ✨ Ask AI About This

About Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹1,546.8 CrP/E: 34.5ROE: 16.5%ROCE: 21.7%Div Yield: 1.70%

View full JAGSNPHARM stock details →

📡 Get AI alerts when JAGSNPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JAGSNPHARM — Free

💡 Ask AI about this filing

"What is the valuation multiple relative to revenue?""How does this affect Jagsonpal's debt ratios?""What are the specific growth drivers in the women's health segment?"

Ask AI Free →

📊 More JAGSNPHARM filings

🔴 Corporate Action — 30 September 2026Jagsonpal Pharmaceuticals announced the allotment of 1,01,825 equity shares of Rs. 2 each under its ...
Announcement — 25 September 2026Jagsonpal Pharmaceuticals has closed its insider trading window effective October 1, 2026, ahead of ...
🟡 Voting Results — 21 September 2026Jagsonpal Pharmaceuticals held its 47th AGM on September 18, 2026 via video conferencing, with votin...
🟡 Board Meeting — 18 September 2026Jagsonpal Pharmaceuticals held its 47th AGM on September 18, 2026 via video conference, electing Man...
🔴 Annual Report — 27 August 2026Jagsonpal Pharmaceuticals held its 47th AGM on September 18, 2026, approving FY26 results with reven...

See all JAGSNPHARM filings →

🔥 Also filed on 23 September 2026

PFOCUSPrime Focus LtdAnnouncement 501261Lords Mark Industries LimitedAnnouncement GREENPOWEROrient Green Power Company LtdCorporate Action PFOCUSPrime Focus LtdAnnouncement GSFCGujarat State Fertilizers & Chemicals LtdAnnouncement GLENMARKGlenmark Pharmaceuticals LtdAnnouncement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when JAGSNPHARM files new disclosures

Track JAGSNPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.